Cornell Financial Engineering Manhattan 2023 Future of Finance Conference
Jennifer E. Miller, PhD, is an Assistant Professor in Yale School of Medicine; Director of the Good Pharma Scorecard (an index that ranks pharmaceutical companies on their bioethical performance); and Founder of the nonprofit Bioethics International. Her research focuses on the ethics of the pharmaceutical industry, specifically developing and using metrics to enhance accountability and social responsibility around how clinical trials are designed, conducted, and disseminated, and the accessibility of new medicines and vaccines. She also works on the ethics of medical and health data sharing and re-use in biomedical research. Prior to joining Yale’s faculty, she was an Assistant Professor in NYU School of Medicine. Her training is in physics, bioethics, regulatory governance, and ethics completed at Fordham University, Regina Apostolorum Pontifical University, Duke University, and Harvard University.
Cornell Financial Engineering Manhattan 2023 Future of Finance Conference
Education & Training
- Postdoctoral FellowshipDuke University (2015)
- Postdoctoral FellowshipHarvard University (2014)
- BSFordham University, Physics (2002)
Activities
- Pharmaceutical Industry Ethics and The Good Pharma ScorecardNew York, United States 2020
- What Makes Medical Data Sharing Ethical?New York, United States 2020
- Clinical Trial Transparency and Data SharingBroadstairs, United Kingdom 2020
- Panel on Genomic Medicine EthicsSan Diego, United States 2020
- EHR Data Sharing: What Makes Data Sharing Ethical?Philadelphia, United States 2020
- Bioethics and Controversial Trends in Healthcare InnovationNew York, United States 2020
- Responsible Data Sharing in Medicine and Clinical ResearchMontreal, Canada 2020
- Non-Trial Preapproval Access to Investigational Medical ProductsNew York, United States 2020
- Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences IndustryCoral Gables, United States 2020
- Oral PresentationPhiladelphia, United States 2020
- Global Health Justice and Access to MedicinesBinghamton, United States 2020
- Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma ScorecardOttawa, Canada 2019
- Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical IndustryCambridge, United States 2019
- Ethics of Clinical Trials and Data PrivacyJerusalem, Israel 2019
- Access to Emerging Therapies for Genetic DisordersRochester, United States 2019
- Responsible Clinical Trial Transparency and Data SharingPhiladelphia, United States 2019
- Responsible Data SharingPhiladelphia, United States 2019
- Brain Health and Performance Summit, Whose Data are They?Columbus, United States 2019
- Inaugural Councils MeetingSan Francisco, United States 2019
- Progress Towards the Sustainable Development GoalsPrinceton, United States 2019
- Ethics of Data-Sharing in Digital MedicineBoston, United States 2019
- Roundtable on Data-Sharing in MedicineLos Angeles, United States 2019
- Ethics of Big Data and AI in RadiologyNew York, United States 2019
- Social Responsibility in PharmaPhiladelphia, United States 2019
- Breaking Barriers to Health Data GovernanceSan Francisco, United States 2019
- Ethics of Federated ModelsSan Francisco, United States 2019
- Solutions Approach to Data Privacy and EthicsWashington, United States 2019
- Establishing a Pharma Code of EthicsBarcelona, Spain 2019
- Preventing the Cambridge Analytica of Health DataAustin, United States 2019
- Data-sharing Principles in MedicineBethesda, United States 2019
- Ethics of Emerging BiotechnologiesDubai, United Arab Emirates 2018
- Opening Keynote: The Ethics of Big Data in Healthcare. October 24, 2018New York, United States 2018
- The Future of Health Summit, Panel on InnovationLos Angeles, United States 2018
- Measuring Impact in Patient-Centered Drug DevelopmentBethesda, United States 2018
- Blockchain as Pharma’s Trust CatalystMadrid, Spain 2018
- Deconstructing Clinical Trials: The Core of Drug Development and Company ValuationsLondon, United Kingdom 2018
- Keynote, Ethics and Trust in Healthcare InnovationNew York, United States 2018
- Research Ethics WorkshopNew York, United States 2018
- Promise and Reality of Clinical Trial Transparency and Data-sharingLondon, United Kingdom 2018
- Ethics and Governance and Healthcare InnovationNew York, United States 2018
- Clinical Trial Transparency and Data-sharing in Healthcare InnovationNew York, United States 2018
- Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals MarketplaceBaltimore, United States 2018
- Big Data and EthicsNew York, United States 2018
- Ethics of Big Data, Machine Learning and AINew York, United States 2018
- Elevate Organizational and New Drug Clinical Trial Transparency Best PracticesPhiladelphia, United States 2018
- Lecture on Pharmaceutical EthicsAugusta, United States 2017
- Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma ScorecardAugusta, United States 2017
- Augmented Humans: Are Super Humans the New Reality?Dubai, United Arab Emirates 2017
- Cybersecurity’s Accelerating Threat: The Impact of Evolving TechnologiesNew York, United States 2017
- Returning Lay Summaries to Trial ParticipantsPhiladelphia, United States 2017
- Data-Sharing: Do We Measure Up?Rockville, United States 2017
- The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?New York, United States 2017
- Transparency in HealthcareCambridge, United States 2017
- The Intersecting Worlds of Researchers, Executives and JournalistsGreencastle, United States 2017
- Ethics and Trust in the Pharmaceutical IndustryNew York, United States 2017
- Cyber SecurityNew York, United States 2017
- Clinical Trial Transparency, Data-sharing, and the Good Pharma ScorecardNew Brunswick, United States 2017
- Healthcare Innovation EthicsNew York, United States 2017
- Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma ScorecardLondon, United Kingdom 2017
- Access, Value, and Trust in Healthcare InnovationNewport Beach, United States 2017
- Clinical Trial Transparency, Drug Development, and the Good Pharma ScorecardNew York, United States 2016
- Clinical Trial Transparency and Regulation Conference, Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma ScorecardBasel, Switzerland 2016
- Ethics and Trust in Healthcare InnovationPalo Alto, United States 2016
- Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health SystemsNewark, United States 2016
- Working Together to Serve PatientsNew York, United States 2016
- Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health PolicyNew York, United States 2016
- Ethics and Transparency in Healthcare InnovationPhiladelphia, United States 2016
- The Good Pharma Scorecard: Special Focus on PublicationsTarrytown, United States 2016
- Ethical Issues in Clinical ResearchNew York, United States 2016
- Pharmaceutical Strategy: Ethics and Reputational HazardsNew York, United States 2016
- Ethics and Governance of Healthcare Innovation and the Good Pharma ScorecardNew York, United States 2016
- Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public GoodNew York, United States 2016
- Institutional Corruption and MedicineWashington, United States 2016
- Institutional Corruption and MedicineChattanooga, United States 2016
- Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012New York, United States 2015
- LectureNew York, United States 2015
- Research Spotlight PresentationNew York, United States 2015
- Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?Baltimore, United States 2015
- Transparency and Data Sharing RoundtableCambridge, United States 2015
- LectureNew York, United States 2015
- The Ethics of Healthcare InnovationNew York, United States 2015
- LectureLondon, United Kingdom 2015
- LectureBinghamton, United States 2015
- Institutional Corruption in MedicineCambridge, United States 2015
- Research EthicsNew York, United States 2015
- Ethics, Trust, Global Health and the Pharmaceutical IndustryCambridge, United States 2015
- LectureBinghamton, United States 2015
- Bioethics and Trust in the Industry– Could Rating Help?Cambridge, United States 2015
- Ethics, Trust, Global Health and the Pharmaceutical IndustryDurham, United States 2015
- Shining Light on Healthcare InnovationDurham, United States 2015
- Data-sharing in Clinical TrialsCambridge, United States 2015
- Institutional Corruption in MedicineCambridge, United States 2015
- Ethics, Human Rights and BusinessDurham, United States 2015
- Transparency and Ethics in Healthcare InnovationNewark, United States 2015
- Corruption, Ethics and Governance in Biomedical ResearchDurham, United States 2015
- Compassionate Use and Pre-Approval Access to Experimental DrugsNew York, United States 2015
- Ethics, Human Rights and the Pharmaceutical IndustryDurham, United States 2015
- Transparency and Ethics in Healthcare InnovationNewark, United States 2015
- Adaptive Regulatory Strategies in Healthcare InnovationDurham, United States 2014
- Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?Cambridge, United States 2014
- Ethics in the Pharmaceutical Industry: Could Rating Help?New York, United States 2014
- Bioethics and Trust in the Industry– Could Rating Help?Cambridge, United States 2014
- Ethics and Trust in the Pharmaceutical IndustryMexico City, Mexico 2014
- Truth-telling and the Pharmaceutical IndustryNew York, United States 2014
- Institutional Corruption in Big PharmaCambridge, United States 2014
- Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy ReformCambridge, United States 2014
- Ethical standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy ReformPittsburgh, United States 2014
- Companies’ Global Health Footprint: Could Rating Help?Cambridge, United States 2013
- Globalization and the MarketNew York, United States 2013
- Public Health EthicsWashington, United States 2013
- Bioethics and Trust in the IndustryCambridge, United States 2013
- Bioethics and Trust in the IndustryCambridge, United States 2013
- Ethical Standards in the Pharmaceutical Industry?New York, United States 2013
- Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy ReformAmherst, United States 2013
- Blinding Science: Blinding as a Solution to Institutional CorruptionCambridge, United States 2013
- Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious TimesBoston, United States 2013
- Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious TimesBoston, United States 2013
- Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform StrategiesCambridge, United States 2012
- Pharmaceutical EthicsNew York, United States 2012
- The Ethics of Drug Development and MarketingNew York, United States 2012
- Ethical Standards for the Pharmaceutical Industry?Jersey City, United States 2012
- Why Corruption is Harder to Resolve Than You Think: Lessons from the Politics of Regulatory Regimes, January 14, 2012New Orleans, United States 2012
- The Role of Virtue in Medicine,Chicago, United States 2011
- Ethical Issues in Pediatric Emergency Mass Critical CareBangkok, Thailand 2011
- Introduction to Bioethical FrameworksBangkok, Thailand 2011
- Bioethical Issues in the Globalization of Clinical ResearchAlbany, United States 2011
- Pharmaceutical EthicsDurham, United States 2011
- Genomics, Ethics and Industry PracticeBurnaby, Canada 2011
- Medical Diplomacy: Response to Environmental DisastersNew York, United States 2011
- Ethical Concerns in Biotechnology and Health Care AdvancesWashington, United States 2011
- Next Steps for the Princeton University Open Hearts InitiativeNew Orleans, United States 2011
- Disaster MedicineNew York, United States 2010
- 15-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-third Special Session of the General Assembly (2000)New York, United States 2010
- LectureTampa, United States 2010
- LectureErie, United States 2010
- DebatePrinceton, United States 2010
- Is Common Ground Possible?Princeton, United States 2010
- Who Should be Responsible for Tomorrow’s Drugs?San Diego, United States 2010
- Introduction to Ethical Frameworks and Clinical Decision-MakingNew York, United States 2009
- Climate Change, Public Health and Emergency Preparedness,New York, United States 2009
- Biotechnology in 20 Years: Privatization and Ethical ConsiderationsNew York, United States 2008
- Balancing Autonomy and Community in Promotion of Human DignityNew York, United States 2008
- New Dilemmas in Modern MedicineNew York, United States 2008
- Ethics of Pandemic Decision-making and Allocation of Medical ResourcesErie, United States 2008
- Ethical Frameworks and Disaster PreparednessErie, United States 2008
- New Ethical Dilemmas in MedicineNew York, United States 2008
- Bioethical Frameworks and Pandemic PreparednessNew York, United States 2007
- Did I Hasten My Patient’s Death?Bridgeport, United States 2007
- -Bridgeport, United States 2007
- LectureBridgeport, United States 2007
- Grand Rounds LectureBridgeport, United States 2007
- Ethics of Adoption and Freezing of Embryos and Natural LawNew York, United States 2005
- Stem Cell Research Ethics, Course Lecture for Philosophical EthicsNew York, United States 2002
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Center for the Fourth Industrial Revolution, Precision Medicine Council | Appointment to World Economic Forum | 2019 |
| Biotechnology Council | Appointment to World Economic Forum | 2018 |
| Futures Council | Appointment to World Economic Forum | 2017 |
| Human Enhancement Working Group | Appointment to World Economic Forum | 2017 |
| Ethical Issues in Global Population Health, Foundation Brocher | Fellow | 2014 |
| United Nations Educational Social and Cultural Organization (UNESCO) Global Ethics Observatory | Appointed | 2009 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Present Working Group Member, Consortia for Improving Medicine with Innovation and Technology (CIMIT), Yale University (NIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2) directed at Yale by Michael K. Dempsey & at Harvard by Steven Schachter | NIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter | 2020 |
| Yale Pediatric Nephrology Residents Research Ethics Lecture (March 27, 2020) | Lecturer | 2020 |
| Yale Data Day, Cushing Whitney Medical Library Class: “Data and Privacy: Day of Data Series Panel Discussion, Yale Medical School Library (February 13, 2020) | Participant | 2020 |
| Yale Center For Clinical Investigation (YCCI), NCATS Clinical Translational Science Award (CTSA), Mount Sinai Curriculum for Bioethics Training in Data Science and AI | Lead | 2020 – Present |
| Present Yale Equity Research and Innovation Center (ERIC), Covid Disparities Working Group | Member | 2020 – Present |
| Expanded Access Program for Covid-Related Drugs and ALS Program, Ethics Committee, Alexion Pharmaceuticals | Committee Member | 2020 – Present |
| Scientific American, Science for Good | Editor | 2020 – Present |
| Alexion Pharmaceuticals Ethics Committee, Expanded Access Program for Covid-Related Drugs and ALS Program | Committee Member | 2020 – Present |
| Consortia for Improving Medicine with Innovation and Technology (CIMIT), NIH-funded U54 Coordinating Center | NIH-funded U54 Coordinating Center focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter | 2020 – Present |
| Committee on Standards for Data Collection and Use, IEEE | Advisor | 2019 – 2020 |
| Yale Law School Health Data Workshop Co-Chair with Chris Morten, Joe Ross, Jen Pinsoff, Amy Kapczynski | Co-Chair | 2019 |
| Yale Digital Medicine Symposium, Ethical Considerations in Digital Medicine, April 26, 2019 | Presenter/Speaker | 2019 |
| Nature Medicine | Reviewer | 2019 – Present |
| BMC Medicine | Reviewer | 2019 – Present |
| The Journal of Bioethics | Reviewer | 2019 – Present |
| Yale Law School, Center for Research and Integrity | Member | 2018 – 2019 |
| Yale Law School MFIA Clinic, Data-Sharing in Medicine, Supervisor | Lead | 2018 – 2019 |
| Director’s Working Group on Ethical Considerations for Industry Partnership on Research to Help End the Opioid Crisis, NIH | Committee Member | 2018 |
| New England Journal of Medicine (NEJM) | Reviewer | 2018 – Present |
| The British Medical Journal (BMJ) | Reviewer | 2018 – Present |
| World Economic Forum | Member | 2017 – Present |
| New York University (NYU) School of Medicine, Pharmacy and Therapeutics Committee | Committee Member | 2016 – 2019 |
| Pharmacy and Therapeutics Committee, NYU School of Medicine | Committee Member | 2016 – Present |
| NYU Electronic Medical Records (EMR) Working Group, New York University | Tasked with developing new guidelines for incorporating clinical research into Epic | 2016 – Present |
| The Journal of the American Medical Association (JAMA) Internal Medicine | Reviewer | 2016 – Present |
| Institutional Review Board, Embryonic Stem Cell Research Oversight, New York University (NYU) School of Medicine | Committee Member | 2015 – 2019 |
| Compassionate Use and Expanded Access Committee, Johnson and Johnson (J&J) and New NYU School of Medicine | Scientific Advisor | 2015 – 2017 |
| Committee on Data Sharing and Transparency, Harvard University Multi-Regional Clinical Trials Initiative | Board Member | 2015 – 2016 |
| Journal of Evidence-based Medicine & Public Health | Editor | 2015 – 2016 |
| Advanced Disaster Life Support (ADLS®) | Ethical and Legal Considerations (Chapter 5), Advanced Disaster Life Support (ADLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer) | 2015 |
| Core Disaster Life Support (CDLS®) | Legal and Ethical Issues (Chapter 5), Core Disaster Life Support (CDLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer) | 2015 |
| Embryonic Stem Cell Research Oversight Committee, NYU School of Medicine | Committee Member | 2015 – Present |
| Journal of Clinical Pharmacology | Reviewer | 2015 – Present |
| Stem Cells Translation Medicine | Reviewer | 2015 – Present |
| Pragmatic Clinical Trials Initiative, Gatekeepers Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research Network | Board Member | 2014 – 2015 |
| Pragmatic Clinical Trials Initiative, Vulnerable Subjects Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research Network | Board Member | 2014 – 2015 |
| Public Library of Science (PLOS ONE) | Reviewer | 2014 – Present |
| Criteria for Data Sharing Subgroup, Harvard University Multi-Regional Clinical Trials Initiative | Co-Chair | 2013 – 2014 |
| Pharmaceutical Regulatory Affairs: Open Access, OMICS Publishing Group | Reviewer | 2013 – Present |
| Law and Society Association, Institutional Corruption | Committee Member | 2012 – 2015 |
| Ethics Committee, Harvard University Multi-Regional Clinical Trials Initiative | Committee Member | 2012 – 2014 |
| American Society of Bioethics and Humanities | Member | 2012 – Present |
| Advisory Board, Center for Policy and Emerging Technologies | Advisor | 2010 – 2015 |
| Center for Policy and Emerging Technologies, Center for Policy and Emerging Technologies | Advisor | 2010 – 2015 |
| Center for Policy and Emerging Technologies, Advisory Board | Board Member | 2010 – 2015 |
| Ethics Committee and IRB Workshop Director, Tampa General Hospital, Morsani College of Medicine, University of South Florida | Director | 2010 |
| Pediatric Emergency Mass Critical Care Taskforce, Steering Committee, Centers for Disease Control and Prevention (CDC) | Committee Member | 2009 – 2011 |
| Pediatric Emergency Mass Critical Care Taskforce, Ethics Committee, Centers for Disease Control and Prevention (CDC) | Committee Member | 2009 – 2011 |
| Pandemic and Emergency Preparedness Ethics Grand Rounds Director, St. Vincent’s Health System (Pennsylvania) | Director | 2008 |
| Pandemic and Emergency Preparedness Ethics Grand Rounds Director for the Department of Emergency Medicine, Hamot Hospital (Pennsylvania) | Director | 2008 |
| American Medical Association, National Disaster Life Support Education Consortium | Member | 2007 – 2011 |
| American Museum of Natural History, Junior Advisory Council | Council Member | 2007 – 2011 |
| ICU Rounds on End of Life Care Ethics, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Medical Ethics Lecturer for Radiology and Transitional Year Residency Program, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Medical Ethics Lecturer for Internal Medicine Department, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Pandemic and Emergency Preparedness Ethics Hospital-Wide Grand Rounds, St. Vincent’s Medical Center (Connecticut) | Lecturer | 2007 |
| Bioethics International | President | 2006 – Present |
| Bioethics International | Board Member | 2005 – Present |
| Bellevue Hospital, High School Pediatric Psychiatric Ward Volunteers, Volunteer Director | Director | 2004 – 2006 |
Cornell Financial Engineering Manhattan’s 2022 Future Of Finance Conference Speaker Profile: Dr. Jennifer Miller Assistant Professor Yale School of Medicine
Cornell Financial Engineering Manhattan 2023 Future of Finance Conference
